Rabe, Baby Boy .

HRN: 29-32-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/16/2026
07/23/2026
IV
33mg
Q24h
PSNB; T/c Neonatal Pneumonia
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: